SEC Form 4 · accession 0001209191-18-057431
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara B Hill
Director
Period of report
Nov 5, 2018
Accepted (ET)
Nov 6, 2018 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 5, 2018 | P | 3,705 | $53.8956 | A | 63,381 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of sale prices was $53.7131 to $53.99.